Toggle Main Menu Toggle Search


A real life retrospective analysis of drug expenditure reveals no significant cost difference between infliximab and adalimumab in the treatment of Adult Crohn's Disease

Lookup NU author(s): Dr Chris Lamb, Maria Price, Dr John Mansfield


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Lamb CA, Price M, Robinson M, Gunn MC, Thompson NP, Mansfield JC

Publication type: Conference Proceedings (inc. Abstract)

Conference Name: Annual Meeting of the British Society of Gastroenterology

Year of Conference: 2011

Pages: A251-A252



Publisher: Gut: BMJ Publishing Group


DOI: 10.1136/gut.2011.239301.534

Library holdings: Search Newcastle University Library for this item



    Link to this publication